Co-Authors
This is a "connection" page, showing publications co-authored by NABIL AHMED and Ahmed GAD.
Connection Strength
0.986
-
Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers. Cytotherapy. 2016 11; 18(11):1382-1392.
Score: 0.562
-
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial. Nat Cancer. 2024 Jun; 5(6):880-894.
Score: 0.239
-
Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2021 Jun; 27(6):1117-1120.
Score: 0.049
-
Targeting hydrogen sulphide signaling in breast cancer. J Adv Res. 2021 Jan; 27:177-190.
Score: 0.046
-
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2020 05; 26(5):720-731.
Score: 0.045
-
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia. 2021 01; 35(1):75-89.
Score: 0.045